Data & access communications

Supporting brands throughout their lifecycle

From data announcements to marketing authorisation, through to health technology assessments, new indications and loss of exclusivity, Red has extensive experience supporting brands both pre and post launch. We understand how to turn complex science into simple, salient messages that cut through to drive editorial, engage stakeholders and influence HCPs, policymakers and commissioners.


We launched the first treatment available via the Early Access to Medicines Scheme. We have delivered competitor-beating editorial not only for first in class treatments, but second, third and fourth in class too. Plus we’ve managed media and stakeholder engagement around patent expiry for some of the most high-profile treatments of the last decade.

< Back Next Corporate reputation > Close